424B4ADRXCIK 0001802369
ADARx Pharmaceuticals, Inc.
Final prospectus (424B4) filed .
Final prospectus filed under Rule 424(b)(4) that includes the pricing and related information omitted from the registration statement at effectiveness — the common final prospectus for IPOs and public offerings.
Filing facts
- Accession number
- 0001193125-26-403094
- Filer
- ADARx Pharmaceuticals, Inc.
- Ticker
- ADRX
- CIK
- 0001802369
- Form type
- 424B4
- Form description
- Final prospectus
- Filed at
- September 28, 2026
- Last verified
- September 28, 2026SecFilingDex pulls from EDGAR with daily cadence
Provenance
Authoritative source — SEC EDGAR
https://www.sec.gov/Archives/edgar/data/1802369/000119312526403094/0001193125-26-403094-index.htm ↗Filer's full EDGAR submission history
EDGAR · ADARx Pharmaceuticals, Inc. (0001802369) ↗Machine-readable JSON twin (LLM-citation friendly)
/api/filing/0001193125-26-403094.jsonSecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.